| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Revenue: | ||||||
Revenue | ||||||
6,347 | - | |||||
Operating expenses: | ||||||
Research and development | ||||||
34,216 | 19,787 | |||||
General and administrative | ||||||
9,613 | 3,409 | |||||
Total operating expenses | ||||||
43,829 | 23,196 | |||||
Income (loss) from operations | ||||||
-37,482 | -23,196 | |||||
Other income, net | ||||||
3,745 | 397 | |||||
Net income (loss) | ||||||
-33,737 | -22,799 | |||||
Shares used in the calculation of earnings (loss) per share | ||||||
Net loss per common share—basic and diluted (in dollars per share) | ||||||
-2.15 | -16.64 | |||||
Weighted average number of common shares —basic and diluted (in shares) | ||||||
15,695 | 1,369 | |||||
Comprehensive income (loss): | ||||||
Net income (loss) | ||||||
-33,737 | -22,799 | |||||
Unrealized loss on marketable securities | ||||||
-38 | - | |||||
Total comprehensive income (loss) | ||||||
-33,775 | -22,799 | |||||